• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Agiliti Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    5/7/24 9:02:32 AM ET
    $AGTI
    Managed Health Care
    Health Care
    Get the next $AGTI alert in real time by email
    8-K
    AGILITI, INC. \DE NYSE false 0001749704 --12-31 0001749704 2024-05-07 2024-05-07

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 7, 2024

     

     

    AGILITI, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-40361   83-1608463
    (State or other jurisdiction
    of incorporation)
     

    (Commission

    File Number)

      (I.R.S. Employer
    Identification No.)

     

    11095 Viking Drive, Suite 300

    Eden Prairie, MN 55344

      55344
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (952) 893-3200

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Title of each class

     

    Trading
    Symbol

     

    Name of each exchange
    on which registered

    Common Stock, par value $0.0001   AGTI   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

     

     

     


    Introduction

    On May 7, 2024 (the “Closing Date”), Agiliti, Inc., a Delaware corporation (the “Company”), completed its previously announced merger with Apex Merger Sub, Inc., a Delaware corporation (“Merger Sub”), pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 26, 2024, by and among the Company, Apex Intermediate Holdco, Inc., a Delaware corporation (“Parent”) and Merger Sub (the “Merger Agreement”).

    The Company merged with and into Merger Sub with the Company surviving the merger as a subsidiary of Parent (“Surviving Corporation” and such merger, the “Merger”). The description of the Merger Agreement and related transactions (including, without limitation, the Merger) in this Form 8-K does not purport to be complete and is subject and qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 26, 2024 and incorporated herein by reference.

     

    Item 1.01

    Entry into a Material Definitive Agreement.

    On May 7, 2024, Agiliti Health, Inc. (the “Borrower”) and Agiliti Holdco, Inc., each a subsidiary of the Company, and certain of their subsidiaries, entered into an amendment (the “First Amendment”) to the Borrower’s Amended and Restated Credit Agreement, dated May 1, 2023 (as amended, the “Credit Agreement”), among the Borrower, the lenders party thereto, the subsidiary guarantors party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent. Among other things, the First Amendment increased the principal amount of initial term loans by $400 million under a new incremental term facility, which otherwise has the same terms as those applicable to the existing initial term loans under the Credit Agreement. The net proceeds from the new incremental term facility were used to pay Merger Consideration (defined below) in addition to general corporate purposes such as paying down borrowings under that certain Receivables Financing Agreement, dated February 14, 2024, among Agiliti Receivables LLC, a subsidiary of the Company, the Borrower, the lenders party thereto, the group agents party thereto and MUFG Bank, Ltd., as administrative agent.

     

    Item 2.01

    Completion of Acquisition or Disposition of Assets.

    The information set forth in the Introduction of this Current Report on Form 8-K is incorporated herein by reference.

    Upon consummation of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, each share of common stock, $0.0001 par value per share of the Company, (the “Shares” and each, a “Share”) issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than (i) Shares owned directly or indirectly by THL Agiliti LLC (the “Significant Company Stockholder”), Parent or Merger Sub or any of their respective subsidiaries (each such Share referred to in clause (i), a “Significant Company Stockholder Share” and, collectively, the “Significant Company Stockholder Shares”), (ii) certain Shares (“Rollover Shares”) held by Thomas J. Leonard (the “Rollover Stockholder”) who agreed to roll over a certain portion of his Rollover Shares and/or restricted stock units (“RSUs” and together with the Rollover Shares, the “Retained Equity Interests”) into equity of the Surviving Corporation or a newly formed parent entity of the Surviving Corporation or Parent in lieu of the treatment of such Retained Equity Interests under the Merger Agreement, (iii) Shares owned by the Company as treasury stock and (iv) Shares that are owned by stockholders who have perfected and not withdrawn a demand for appraisal rights in accordance with Section 262 of the Delaware General Corporation Law (“Dissenting Stockholders”)), was converted into the right to receive $10.00 per Share in cash, without interest thereon (the “Merger Consideration”).

    The Significant Company Stockholder Shares that were issued and outstanding immediately prior to the Effective Time were converted into an equal number of shares of common stock, par value $0.0001, of the Surviving Corporation and remain outstanding.

    The Retained Equity Interests comprised of Rollover Shares held by the Rollover Stockholder issued and outstanding immediately prior to the Effective Time were converted into one share of common stock, par value $0.0001, of the Surviving Corporation.

     

    2


    The Retained Equity Interests comprised of RSUs were “rolled-over” into restricted stock units subject to the same terms and conditions that applied to the corresponding RSUs prior to the Closing (other than for any such terms rendered inoperative by reason of the transactions contemplated by the Merger Agreement or for such other administrative or ministerial changes that are reasonable and made in good faith in connection with the administration of such award following the Effective Time), which restricted stock units will, upon vesting, be settled in shares of the Surviving Corporation or a newly formed parent entity of the Company or Parent.

    Each Share owned by the Company as treasury shares issued and outstanding immediately prior to the Effective Time, was cancelled without payment of any consideration therefor and has ceased to exist.

    Each Share held by a Dissenting Stockholder has ceased to be outstanding, was cancelled without payment of any Merger Consideration therefor, and was automatically converted into the right to receive the appraised value of such dissenting Share in accordance with the provisions of Section 262 unless such holder fails to comply with the procedures described in Section 262 of the Delaware General Corporation Law or effectively withdraws or otherwise loses such holder’s rights to receive payment under Section 262 of the Delaware General Corporation Law, in which case they will receive the Merger Consideration.

    Pursuant to the Merger Agreement, except as otherwise agreed by Parent and the applicable holder thereof and other than with respect to the Rollover RSUs, at the Effective Time, each outstanding and unexercised option (an “Option”) to purchase Shares (other than rights to purchase Shares under the Company’s Employee Stock Purchase Plan) granted under the Agiliti, Inc. Amended and Restated 2018 Omnibus Incentive Plan, the 2007 Stock Option Plan of Agiliti Holdco, Inc. or the Agiliti Holdco, Inc. 2018 Executive Management Stock Option Plan (each, a “Company Stock Plan”), each award of time-based RSUs granted under a Company Stock Plan, award of performance restricted stock units granted in 2021 under a Company Stock Plan (a “2021 Performance Restricted Stock Unit”), and award of performance restricted stock units granted in 2022 or 2023 under a Company Stock Plan (a “2022/2023 Performance Restricted Stock Unit”) received the following treatment:

     

      •  

    each Option, whether or not vested, that was not an Underwater Option (defined below) (an “In-the-Money Option”) was terminated and cancelled in exchange for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (1) the number of Shares underlying the In-the-Money Option immediately prior to the Effective Time, multiplied by (2) an amount equal to the excess of the Merger Consideration over the applicable exercise price of such In-the-Money Option.

     

      •  

    each Option with an exercise price that is equal to or greater than the Merger Consideration (each, an “Underwater Option”) was terminated and cancelled with no payment due to the holder thereof.

     

      •  

    each unvested and outstanding RSU remains issued and outstanding and generally subject to the same terms and conditions as those that applied immediately prior to the Effective Time, except that: (i) RSUs held by each employee of the Company or its subsidiaries who is employed immediately prior to the Closing and continues to remain employed with the Company or its subsidiaries following the Closing (each, a “Continuing Employee”) at or above the level of “Vice President” will be settled in Shares or other equity interests in the Company or one of its affiliates, as determined by the board of directors of Parent or its applicable affiliate (the “Parent Board”) in its sole discretion, with applicable withholding taxes satisfied through net share settlement; and (ii) RSUs held by all other grantees will be settled in cash based on the fair market value of a share of stock or other equity interest in the Company or one of its affiliates as determined by the Parent Board in its sole discretion.

     

      •  

    each outstanding vested RSU was terminated and cancelled in exchange for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (i) the number of Shares subject to the RSUs, multiplied by (ii) $10.00.

     

      •  

    to the extent that the 2021 Performance Restricted Stock Units were outstanding or payable as of immediately prior to the Effective Time, except as otherwise provided under the Merger Agreement, such award was fully vested and was terminated and cancelled in exchange for the right to receive a cash payment, without interest thereon and subject to applicable withholding taxes, equal to (i) the number of Shares subject to such 2021 Performance Restricted Stock Unit that were earned under the terms of such 2021 Performance Restricted

     

    3


     

    Stock Unit based on the actual level of achievement (as determined by the compensation committee of the board of directors of the Company in accordance with the applicable Company Stock Plan and award agreement evidencing such awards), multiplied by (ii) $10.00.

     

      •  

    each 2022/2023 Performance Restricted Stock Unit that was outstanding or payable as of immediately prior to the Effective Time remains issued and outstanding and generally subject to the same terms and conditions (including with respect to time- and performance-based vesting conditions and settlement terms) as those that applied immediately prior to the Effective Time, except: (i) any total shareholder return performance vesting conditions will no longer apply; (ii) each 2022/2023 Performance Restricted Stock Unit held by Continuing Employees at or above the level of “Vice President” will be settled in Shares or other equity interests in the Company or one of its affiliates, as determined by the Parent Board in its sole discretion, with applicable withholding taxes satisfied through net share settlement; and (iii) each 2022/2023 Performance Restricted Stock Unit held by all other grantees will be settled in cash based on the fair market value of a share of stock or other equity interest in the Company or one of its affiliates as determined by the Parent Board in its sole discretion.

    The description of the Merger set forth above does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, which was filed by the Company as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 26, 2024.

    The information in the Introduction above and in Item 3.03 and Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.

     

    Item 2.03

    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

     

    Item 3.01

    Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    On May 7, 2024, in connection with the closing of the Merger, the Company notified the New York Stock Exchange (“NYSE”) that the Merger had been consummated. The Company has requested that the NYSE delist its Shares and, as a result, trading of the Shares on the NYSE was suspended prior to the opening of the NYSE on May 7, 2024. The Company also requested that the NYSE file a notification of removal from listing and registration on Form 25 with the SEC to effect the delisting of the Shares from NYSE and the deregistration of the Shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

    Additionally, the Company intends to file with the SEC a Form 15 requesting the termination of registration of the Shares under Section 12(g) of the Exchange Act and the suspension of reporting obligations under Sections 13 and 15(d) of the Exchange Act.

    The information set forth in the Introduction, under Item 2.01 and Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference.

     

    Item 3.03

    Material Modification to Rights of Security Holders.

    As a result of the consummation of the Merger, at the Effective Time, each Share (other than Significant Company Stockholder Shares and Rollover Shares) was canceled and automatically converted into the right to receive the Merger Consideration.

    The information set forth in the Introduction, under Item 2.01 and Item 3.01 of this Current Report on Form 8-K is incorporated herein by reference.

     

    4


    Item 5.03

    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

    Pursuant to the terms of the Merger Agreement, at the Effective Time, the certificate of incorporation of the Company, in effect immediately prior to the Effective Time, was amended and restated in its entirety (the “Third Amended and Restated Certificate of Incorporation”) and the Company’s bylaws, in effect immediately prior to the Effective Time, were amended and restated in their entirety (the “Fourth Amended and Restated Bylaws”).

    Copies of the Third Amended and Restated Certificate of Incorporation and the Fourth Amended and Restated Bylaws are filed as Exhibit 3.1 and Exhibit 3.2 respectively, and are both incorporated herein by reference.

     

    Item 8.01

    Other Events.

    On May 7, 2024, the Company issued a press release announcing that the closing of the Merger. A copy of the press release is filed as Exhibit 99.1 and is incorporated herein by reference.

     

    Item 9.01

    Financial Statements and Exhibits.

    (c) Exhibits.

     

     2.1*    Agreement and Plan of Merger, dated as of February 26, 2024, by and among the Company, Parent and Merger Sub (incorporated herein by reference to Exhibit 2.1 to the Current Report on Form 8- K filed by the Company on February 26, 2024).
     3.1    Third Amended and Restated Certificate of Incorporation of Agiliti, Inc., dated as of May 7, 2024.
     3.2    Fourth Amended and Restated Bylaws of Agiliti, Inc., dated as of May 7, 2024.
    99.1    Press Release, dated as of May 7, 2024.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    *

    Schedules and exhibits to this agreement have been omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the SEC upon its request.

     

    5


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

            

    Agiliti, Inc.

         (Registrant)

    May 7, 2024

          

    /s/ James B. Pekarek

         James B. Pekarek
         Executive Vice President and Chief Financial Officer
    Get the next $AGTI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AGTI

    DatePrice TargetRatingAnalyst
    3/7/2024$10.00Buy → Neutral
    UBS
    2/6/2024Sector Weight
    KeyBanc Capital Markets
    1/4/2024$23.00Buy
    Craig Hallum
    11/14/2023$16.00 → $10.00Neutral → Buy
    UBS
    9/5/2023$18.00 → $11.00Neutral → Underperform
    BofA Securities
    8/24/2023$15.00 → $10.00Equal-Weight → Underweight
    Morgan Stanley
    8/15/2023$20.00 → $13.00Buy → Neutral
    Citigroup
    8/10/2023Outperform → Mkt Perform
    Raymond James
    More analyst ratings

    $AGTI
    Leadership Updates

    Live Leadership Updates

    See more
    • DigitalOcean Holdings Set to Join S&P SmallCap 600

      NEW YORK, April 30, 2024 /PRNewswire/ -- DigitalOcean Holdings Inc. (NYSE:DOCN) will replace Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 7. Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 7, 2024 S&P SmallCap 600 Addition DigitalOcean Holdings DOCN Information Technology S&P SmallCap 600 Deletion Agiliti AGTI Health Care For more information about S&P Dow Jones Indices,

      4/30/24 5:38:00 PM ET
      $AGTI
      $DOCN
      $SPGI
      Managed Health Care
      Health Care
      Computer Software: Programming Data Processing
      Technology
    • Agiliti Announces CEO Transition

      Tom Leonard returns as Chief Executive Officer Agiliti, Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that the Agiliti Board of Directors has appointed Tom Leonard as Chief Executive Officer. Leonard succeeds Tom Boehning who is no longer with the company. Leonard previously served as CEO of Agiliti from April 2015 until his retirement from the company in March 2023. He served as a member of the company's Board of Directors following his retirement and will remain a Board member as he returns to the role of CEO. "Tom Leonard led the company through eight years of profitable growth

      10/2/23 8:00:00 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • Enhabit Announces Agreement with Cruiser Capital and Harbour Point Capital

      Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet

      3/30/23 8:46:00 AM ET
      $AGTI
      $CVS
      $EHAB
      $THC
      Managed Health Care
      Health Care
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $AGTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Agiliti downgraded by UBS with a new price target

      UBS downgraded Agiliti from Buy to Neutral and set a new price target of $10.00

      3/7/24 7:23:43 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • KeyBanc Capital Markets initiated coverage on Agiliti

      KeyBanc Capital Markets initiated coverage of Agiliti with a rating of Sector Weight

      2/6/24 6:20:18 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • Craig Hallum initiated coverage on Agiliti with a new price target

      Craig Hallum initiated coverage of Agiliti with a rating of Buy and set a new price target of $23.00

      1/4/24 8:00:09 AM ET
      $AGTI
      Managed Health Care
      Health Care

    $AGTI
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $AGTI
    SEC Filings

    See more

    $AGTI
    Financials

    Live finance-specific insights

    See more

    $AGTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Agiliti Announces Closing of Acquisition by THL

      Agiliti Taken Private for $10.00 per Share in Cash Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"). On February 26, 2024, Agiliti announced that THL had signed a definitive agreement to purchase all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates or certain management and director shareholders for $10.00 per share, implying a total enterprise value of $2.5 billion. "The work we do at Agiliti has strengthened our nation's healthcar

      5/7/24 8:55:00 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • DigitalOcean Holdings Set to Join S&P SmallCap 600

      NEW YORK, April 30, 2024 /PRNewswire/ -- DigitalOcean Holdings Inc. (NYSE:DOCN) will replace Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 7. Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 7, 2024 S&P SmallCap 600 Addition DigitalOcean Holdings DOCN Information Technology S&P SmallCap 600 Deletion Agiliti AGTI Health Care For more information about S&P Dow Jones Indices,

      4/30/24 5:38:00 PM ET
      $AGTI
      $DOCN
      $SPGI
      Managed Health Care
      Health Care
      Computer Software: Programming Data Processing
      Technology
    • Agiliti Announces Financial Results for Fourth Quarter and Full-Year 2023

      Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenue growth of 4% to $292 million Net loss of $5.7 million, compared to net income of $3.4 million in the prior year period; diluted loss per share of $0.04, compared to diluted earnings per share of $0.02 in the prior year period Adjusted EBITDA1 of $67.3 million, compared to $71.4 million in the prior year period; Adjusted Earnings Per Share1 of $0.13, compared to $0.18 in the prior year period Full-Yea

      3/5/24 4:05:00 PM ET
      $AGTI
      Managed Health Care
      Health Care
    • SEC Form 15-12G filed by Agiliti Inc.

      15-12G - AGILITI, INC. \DE (0001749704) (Filer)

      5/17/24 7:51:55 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • SEC Form EFFECT filed by Agiliti Inc.

      EFFECT - AGILITI, INC. \DE (0001749704) (Filer)

      5/14/24 12:15:20 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • SEC Form 10-Q filed by Agiliti Inc.

      10-Q - AGILITI, INC. \DE (0001749704) (Filer)

      5/7/24 1:41:34 PM ET
      $AGTI
      Managed Health Care
      Health Care
    • Agiliti Announces Financial Results for Fourth Quarter and Full-Year 2023

      Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenue growth of 4% to $292 million Net loss of $5.7 million, compared to net income of $3.4 million in the prior year period; diluted loss per share of $0.04, compared to diluted earnings per share of $0.02 in the prior year period Adjusted EBITDA1 of $67.3 million, compared to $71.4 million in the prior year period; Adjusted Earnings Per Share1 of $0.13, compared to $0.18 in the prior year period Full-Yea

      3/5/24 4:05:00 PM ET
      $AGTI
      Managed Health Care
      Health Care
    • Agiliti to Be Taken Private by THL Partners

      Unanimously Recommended by Special Committee of the Agiliti Board of Directors Agiliti Shareholders to Receive $10.00 per Share in Cash, Representing Premia of 39% and 43% Over Agiliti's 30-Day and 90-Day Volume Weighted Average Price Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that it has entered into a definitive merger agreement pursuant to which an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"), the company's majority shareholder, will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain

      2/26/24 8:00:00 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • Agiliti Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

      Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on Tuesday, March 5, 2024, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13743834. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13743834. The replay will be available until March 19, 2024. Interested inve

      2/14/24 8:00:00 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • Harris C Martin returned $191,500 worth of shares to the company (19,150 units at $10.00), closing all direct ownership in the company (SEC Form 4)

      4 - AGILITI, INC. \DE (0001749704) (Issuer)

      5/7/24 10:37:58 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • Patrick Diane B. returned $369,010 worth of shares to the company (36,901 units at $10.00), closing all direct ownership in the company (SEC Form 4)

      4 - AGILITI, INC. \DE (0001749704) (Issuer)

      5/7/24 10:36:56 AM ET
      $AGTI
      Managed Health Care
      Health Care
    • Friedman Darren M. returned $118,000 worth of shares to the company (11,800 units at $10.00), closing all direct ownership in the company (SEC Form 4)

      4 - AGILITI, INC. \DE (0001749704) (Issuer)

      5/7/24 10:36:06 AM ET
      $AGTI
      Managed Health Care
      Health Care

    $AGTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Agiliti Inc.

      SC 13G - AGILITI, INC. \DE (0001749704) (Subject)

      2/11/22 4:23:03 PM ET
      $AGTI
      Managed Health Care
      Health Care